Om Biotec Kinolact Oral Solution contains Lactulose (NA) as its active ingredient, a synthetic disaccharide used primarily as a laxative and in the management of hepatic encephalopathy. Lactulose functions by metabolizing in the colon into low molecular weight organic acids, which acidify the colonic contents, leading to an osmotic effect that increases stool water content and promotes bowel movements. This mechanism effectively relieves constipation and facilitates the evacuation of fecal matter. Additionally, in patients with hepatic encephalopathy, Lactulose reduces blood ammonia levels by converting ammonia to ammonium ions in the colon, thereby decreasing systemic absorption and neurotoxic effects. Om Biotec Kinolact Oral Solution is indicated for the treatment of chronic constipation and for the prevention and management of hepatic encephalopathy associated with liver cirrhosis. The solution is administered orally, with dosage tailored according to the severity of the condition and patient response. Common side effects may include abdominal discomfort, flatulence, and diarrhea, which are generally mild and transient. Caution is advised in patients with galactosemia or those requiring electrolyte monitoring. Om Biotec Kinolact Oral Solution offers a well-established therapeutic option with a favorable safety profile for bowel regulation and hepatic encephalopathy management.